IMPLANET (Euronext Growth: ALIMP, FR0013470168, PEA-PME eligible), a medical technology company specializing in spinal implants and knee surgery implants, informs its shareholders that its Combined General Meeting was held on Thursday June 9, 2022 at 2 p.m. at the company’s head office in Martillac.
The number of shares held by the shareholders present or represented was 5,305,617, ie a quorum of 26.96%.
All of the resolutions of this General Meeting were adopted. The minutes of the General Meeting will be available within the legal deadlines on the Company’s website: https://www.implanet-invest.com/assemblee-generale